Stewardship and Surveillance
Pfizer Anti-Infectives: Driving Global Innovation
Pfizer Anti-Infectives is committed to confronting the global challenges of infectious diseases through active stewardship, global policy leadership, access to innovative surveillance tools and delivering a diverse portfolio of medicines to treat patients with serious infections around the world.
- Antimicrobial resistance (AMR) is on the rise and is a critical global public health issue
- Antibiotic resistance leads to increased mortality, longer hospital stays, higher medical costs and loss of productivity
ATLAS: Antimicrobial Testing Leadership and Surveillance
Pfizer sponsors the largest antimicrobial resistance surveillance programme in the industry, spanning 13 years of continuous bacterial monitoring across 60 countries.
It identifies changes in resistance rates for global, regional and local pathogens and notes emergence of new resistant pathogens.
A mobile app providing access to ATLAS data will soon be publically available for smart Phones or iPads.